The impact of genetic risk on the prevalence of advanced fibrosis and cirrhosis in prospectively assessed patients with type 2 diabetes.
Lana BridiSaaket AgrawalKaleb TesfaiEgbert MadambaRicki BettencourtLisa M RichardsAmit V KheraStephen CaldwellVeeral H AjmeraPublished in: Alimentary pharmacology & therapeutics (2024)
Utilising a well-phenotyped, prospective cohort of adults with T2DM, we found that adding an assessment of genetic risk to recommendations to screen at-risk populations may improve risk prediction.